Answers are grounded in this paper and cite their sources.
Medullomyoblastoma (MMB) is a rare variant of medulloblastoma, a member of the family of central nervous system (CNS) embryonal tumors. The outcome of standard therapy for CNS embryonal tumors is often unpredictable in the setting of MMB. Here, we present the clinical course and treatment of an almost 4-year-old girl with MMB that was characterized by MYC amplification, isochromosome 17q and large cell/anaplastic histopathology.
No takes yet. Share an insight, caveat, or question.
Wright et al. (2011) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: